Creative Biogene
As a scientists-founded and scientists-driven leading biotechnological company, Creative Biogene focuses on developing high quality products and services, as well as proprietary technology to support the research in the field of basic life sciences research, biomedical development, industrial synthetic application and preclinical drug discovery.
Press Releases
CAR-T Lentiviral Particles: Revolutionizing Cancer Immunotherapy
•Shirley, New York, 11967
CAR-T cell therapy has emerged as a groundbreaking approach in the fight against cancer, particularly for hematologic malignancies.
Contact: Marcia Brady - marketing director • Email Contact
Showing 1-1 of 1 releases